Fast forward to successful AF therapy selection and lasting AF symptom relief.

The first intelligent AF therapy decision support tool assessing each patient’s own atrial substrate matching the optimal therapy. Save time and achieve higher clinical outcomes.

YourRhythmics is supported by:
YourRhythmics - Demo V1.00_00_28_06.Standbild001

Discover the fast and easy way towards successful AF therapy.

The first AF Therapy Decision Support tool assisting healthcare providers to immediately identify the appropriate therapy and initiate it as early as possible to lower cardiovascular risks for their AF patients.

Non-invasive_icon Immediate insight

Full visualisation of the atrial activation and all meaningful atrial information in real time.

feature-icon Respecting your time

Immediate multi-factor confirmation of your treatment choice in one single time-saving step.

Personalized_Treatment_icon (1) (1) Quality of life

Predicts outcomes to enable a “Fast Forward” to lasting symptom relief for each individual AF patient.

Ease_of_use_icon-1 Easy and simple

High-resolution atrial signal acquisition, as easy and simple as a standard ECG recording.

Discover our HRECG Solution.

  • Confirm symptomatic or asymptomatic AF presence

  • Diagnose and classify AF accurately

  • Immediately identify the appropriate AF therapy

For each individual patient in one single step.

New HR∑ECG
Acquisition System
YourRhythmics - Demo V1.00_01_24_09.Standbild002
Learn more
New HR∑ECG
Analysis Suite
YourRhythmics - Demo V1.00_00_28_06.Standbild001
Learn more

Resources.

Researchers from the group of Prof. U. Schotten and Prof. H. Crijns at Maastricht University Medical Center extensively studied non-invasive characteristics of AF substrate complexity based on the ECG, leading to the development of our HR∑ECG Solution. How ECG-derived parameters quantifying AF complexity can improve AF classification, outcome prediction and optimize therapy for each individual AF patient is featured in many research publications, some presented below.

EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) P. Kirchhof, A.J. Camm, A. Goette, A. Brandes, L. Eckardt, A. Elvan, T. Fetsch, I.C. van Gelder, D. Haase, L.M. Haegeli, F. Hamann, H. Heidbüchel, G. Hindricks, J. Kautzner, K.-H. Kuck, L. Mont, G.A. Ng, J. Rekosz, N. Schoen, U. Schotten, A. Suling, J. Taggeselle, S. Themistoclakis, E. Vettorazzi, P. Vardas, K. Wegscheider, S. Willems, H.J.G.M. Crijns, and G. Breithardt Read more +
ISOLATION (Intensive Molecular and Electropathological Characterization of patientS undergOing atriaL fibrillATion ablatION) Read more +
EXACT-IN-AF (Extended Automated ECG Characterization To Investigate Atrial Fibrillation) Read more +
MAESTRIA (Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation) Read more +
RACE 9 - Observe AF (Device-based rate versus rhythm control treatment in patients with symptomatic recent-onset atrial fibrillation in the emergency department Read more +
The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation Stef Zeemering, Theo A.R. Lankveld, Pietro Bonizzi, Ione Limantoro, Sebastiaan C.A.M. Bekkers, Harry J.G.M. Crijns and Ulrich Schotten Read more +
Atrial Fibrillation Complexity Parameters Derived From Surface ECGs Predict Procedural Outcome and Long-Term Follow-Up of Stepwise Catheter Ablation for Atrial Fibrillation Theo Lankveld, MD; Stef Zeemering, MSc; Daniel Scherr, MD, PhD; Pawel Kuklik, PhD; Boris A. Hoffmann, MD, BSc; Stephan Willems, MD, PhD; Burkert Pieske, MD, PhD; Michel Haïssaguerre, MD, PhD; Pierre Jaïs, MD, PhD; Harry J. Crijns, MD, PhD; Ulrich Schotten, MD, PhD Read more +
P-wave complexity in normal subjects and computer models Mark Potse, Theo A.R. Lankveld, Stef Zeemering, Pieter C. Dagnelie, Coen D.A. Stehouwer, Ronald M. Henry, André C. Linnenbank, Nico H.L. Kuijpers and Ulrich Schotten Read more +
Automated quantification of atrial fibrillation complexity by probabilistic electrogram analysis and fibrillation wave reconstruction S. Zeemering, B. Maesen, J. Nijs, D. H. Lau, M. Granier, S. Verheule and U. Schotten Read more +
The need for standardization of time- and frequency-domain analysis of body surface electrocardiograms for assessment of the atrial fibrillation substrate Ulrich Schotten, Bart Maesen and Stef Zeemering Read more +
Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation Theo Lankveld, MD Cees, B. de Vos, MD, PhD, Ione Limantoro, MD, Stef Zeemering, PhD, Elton Dudink, MD, MSc, Harry J. Crijns, MD, PhD, Ulrich Schotten, MD, PhD Read more +
EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) P. Kirchhof, A.J. Camm, A. Goette, A. Brandes, L. Eckardt, A. Elvan, T. Fetsch, I.C. van Gelder, D. Haase, L.M. Haegeli, F. Hamann, H. Heidbüchel, G. Hindricks, J. Kautzner, K.-H. Kuck, L. Mont, G.A. Ng, J. Rekosz, N. Schoen, U. Schotten, A. Suling, J. Taggeselle, S. Themistoclakis, E. Vettorazzi, P. Vardas, K. Wegscheider, S. Willems, H.J.G.M. Crijns, and G. Breithardt Read more +
The need for standardization of time- and frequency-domain analysis of body surface electrocardiograms for assessment of the atrial fibrillation substrate Ulrich Schotten, Bart Maesen and Stef Zeemering Read more +
The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation Stef Zeemering, Theo A.R. Lankveld, Pietro Bonizzi, Ione Limantoro, Sebastiaan C.A.M. Bekkers, Harry J.G.M. Crijns and Ulrich Schotten Read more +
Atrial Fibrillation Complexity Parameters Derived From Surface ECGs Predict Procedural Outcome and Long-Term Follow-Up of Stepwise Catheter Ablation for Atrial Fibrillation Theo Lankveld, MD; Stef Zeemering, MSc; Daniel Scherr, MD, PhD; Pawel Kuklik, PhD; Boris A. Hoffmann, MD, BSc; Stephan Willems, MD, PhD; Burkert Pieske, MD, PhD; Michel Haïssaguerre, MD, PhD; Pierre Jaïs, MD, PhD; Harry J. Crijns, MD, PhD; Ulrich Schotten, MD, PhD Read more +
P-wave complexity in normal subjects and computer models Mark Potse, Theo A.R. Lankveld, Stef Zeemering, Pieter C. Dagnelie, Coen D.A. Stehouwer, Ronald M. Henry, André C. Linnenbank, Nico H.L. Kuijpers and Ulrich Schotten Read more +
Automated quantification of atrial fibrillation complexity by probabilistic electrogram analysis and fibrillation wave reconstruction S. Zeemering, B. Maesen, J. Nijs, D. H. Lau, M. Granier, S. Verheule and U. Schotten Read more +
Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation Theo Lankveld, MD Cees, B. de Vos, MD, PhD, Ione Limantoro, MD, Stef Zeemering, PhD, Elton Dudink, MD, MSc, Harry J. Crijns, MD, PhD, Ulrich Schotten, MD, PhD Read more +
EXACT-IN-AF (Extended Automated ECG Characterization To Investigate Atrial Fibrillation) Read more +

About YourRhythmics.

YourRhythmics was founded in 2016 as a spin-off of Maastricht University/Maastricht University Medical Center to develop a decision support tool for personalized AF therapy based on non-invasive characterization of the patient’s atrial substrate obtained from comprehensive analysis of the atrial electrophysiological contraction patterns on high-resolution atrial-optimized extended ECG.

YourRhythmics aims to shorten the time frame from diagnosis to lasting symptom relief for AF patients and increase AF therapy success rates by identifying the optimal therapy for each individual patient right at the time of initial diagnosis. Next focus area is identification of individuals at risk for developing AF to support screening and preventive interventions.

YourRhythmics operates from its office at Brightlands Maastricht Health Campus. Its solutions are developed in close cooperation with key researchers of the Maastricht University CARIM School for Cardiovascular Diseases, Maastricht Instruments BV, a product incubator for innovative medical devices, and AIM BV, a specialized manufacturer of electromechanical medical devices.

 

Team
teamphoto1-1
Marjorie Imhoff Marketing and Sales
teamphoto2
Mike Kozlowski Product Development
teamphoto3
Dick van Waes General Affairs
TeamImagePlaceholder
Virginia Keizer Quality Assurance and Regulatory Affairs
TeamImagePlaceholder
Uli Schotten Scientific Affairs
TeamImagePlaceholder
Dave Hampton Research and Technology
TeamImagePlaceholder
Louk Jongen Business Creation

Learn what YourRhythmics can
do for you and your patients.

Get in touch